MedPath

To compare hemodynamic changes in electro convulsive therapy using propofol , ketofol and thiopentone sodium as induction agent

Phase 3
Conditions
Health Condition 1: F203- Undifferentiated schizophrenia
Registration Number
CTRI/2018/09/015856
Lead Sponsor
I
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All patients with age group of 18 years to 65 years are included with ASA grade 1 and 2 .

Exclusion Criteria

Patients with age more than 65 years and less than 18 years and ASA grade 3 and patients with cardiovascular disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath